Commercialization: Page 105
-
PharmaVoice Team/PharmaVoice
On the Calendar
May 10 2006 HBA Woman of the Year Luncheon Hilton New York, New York For more information, contact Healthcare Businesswomen’s Association at 973-575-0606, e-mail [email protected], or visit hbanet.org. May 10-12 PharmaDiscovery Bethesda North Marriott Hotel & Conference Center, North Bethesda...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On the Cover Creative marketing: New challenges, new tools, new attitudes Marketers are turning to a vast array of tools to meet today’s challenges. The hot tools are predominately patient focused instead of the broader, mass- marketing approach of DTC. FEATURES Combination products: Drugs and de...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Biotech pioneer recognized Dr. Zaffaroni Receives 2006 Biotech Heritage Award The Chemical Heritage Foundation (CHF) and Biotechnology Industry Organization (BIO) presented the 8th Annual Biotechnology Heritage Award to Alejandro Zaffaroni, a pioneer of the biotechnology revolution and a legendar...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Model for Success
Alternatives to the integrated pharmaceutical company business model — such as development-only or hybrid models — are taking hold as smaller players contribute to the industry’s value chain. Ansbert Gadicke MPM Capital The development-only business model makes complete sense, but it is extremely...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies McGraw-Hill’s Access Medicine Launches Online Neurology Resource McGraw-Hill Medical Publishing has released Adams and Victor’s Principles of Neurology on its AccessMedicine.com platform. Adams and Victor’s Principles of Neurology...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
In this day and age when individuals are granted almost instant cult status based on subjective, if not dubious, talent, the “star” label can sometimes lose its luster. And while we live in a cynical world, where the next American Idol is about to be crowned by millions of Americans, it’s nice to...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Avoiding Undue Influence
Thought leaders — scientific and clinical experts — play a pivotal role in helping pharma companies identify key topics of interest to physicians. Depending on their role, these KOLs provide launch and sales support or play a critical role in continuing medical education. They provide solid, evid...
By Autumn Konopka • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Alternatives to the integrated pharmaceutical company business model are taking hold as smaller players contribute to the industry’s value chain. Some of these newer players are focusing on specific areas, such as development, while others are creating hybrid models. We asked PharmaVOICE readers ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Modeling Change
Modeling Change Predictive Measures Sharen Godwin VP, Rx Patient Messaging Solutions VIEW on Biotech April 2006 There is a paradigm shift happening within the industry — a modeling change that embraces innovation to improve wellness and the overall healthcare outlook....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Unraveling the Strands of Online Success
Web-based promotional initiatives are cost-effective strategies for biotech companies to promote their technologies and clinical successes to investor communities, but too few consider the proper metrics for successful campaigns. There are countless bits of informa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Lessons from the Garden: Care and Feeding Needed to Grow Great Biotech Brands
Lessons from the Garden: Care and Feeding Needed to Grow Great Biotech Brands VIEW on Biotech April 2006 Branding David Winigrad President Maureen Mangiavas Senior Director, Business Development The 1979 film “Being There” is the memorable story of Chance the Gardener, portrayed by Pet...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Marketplace
Featured Product and Service Showcases Ateb Inc. BioCor Criterium Inc. DVC HealthCare Inc. The Hal Lewis Group Inc. inVentiv Health Medidata Solutions Inc. MedNet Solutions MProven LLC NXLevel Inc. Stinson Brand Innovation Inc. Sudler & Hennessey Directory of Companies by Catego...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Marketplace
Featured Product and Service Showcases AchieveGlobal Campbell Alliance CMR Institute inVentiv Health NXLevel Inc. PLEXUS Learning Designs Inc. TNS Healthcare Wilson Learning Corp. Directory of Companies by Category Career Development Contract Sales E-Learning Executive Coaching ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Creative Marketing: New Challenges, New Attitudes, New Tools
To meet the challenges presented by a number of converging factors that are impacting the status quo, marketers are turning to a vast array of tools. Experts view specialized direct-to-patient communications as the wave of pharma marketing’s future. Programs that include focused messages to targe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Seung Baick James Bruno Advancis Strengthens Sales and Marketing Capability Advancis Pharmaceutical has hired Seung Baick as assistant product director, responsible for planning and executing marketing initiatives for the company’s Keflex antibiotic franchise. Advancis, Germantown, Md...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies DataLabs Launches Products to Enhance e-CDM DataLabs has released DataLabs Clinical, a single data-management system that unifies the functionality of paper data entry (PDE) with the flexibility of electronic data capture (EDC). D...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On the Cover Drugs in the real world There is an increasing need for more information about prescription drugs once they are approved and available to the larger marketplace. Phase IV studies have become important vehicles for postapproval risk-management and drug-safety assessment. Features The ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Damn the Torpedoes, Full Speed Ahead Recent calls from academic ivory towers to end pharmaceutical and device company collaboration with doctors and medical centers are stupefying and potentially dangerous. Stupefying because pharmaceutical companies are often a patient’s best ally against pain, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Birth of a New Market
Women want more than just birth control. They are looking for additional benefits from contraceptives to meet their individual needs. By Cynthia Borda A wide choice of contraceptive products has been introduced to the market in recent years, representing innovative new products and options in bir...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Value of Postmarketing Studies
Timothy Pratt, Ph.D., Chief Marketing Officer and Principal Scientific Advisor of MedNet Solutions Inc., discusses how postmarketing research, just like everything else successful companies do, is all about marketing, and marketing is all about meeting customers’ needs. Properly constructed and e...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Phase IV studies appear to be the hottest thing in clinical research. More and more companies are fulfilling their regulatory commitments, more CROs are benefitting from the outsourced programs, and physicians have additional avenues for bolstering their resumes. But what about the patients — you...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Market for Biochips in Clinical Research Expected to expand As biochip technology makes the transition from bench to bedside in the clinical-trial process, improved patient therapies will result, according to a recent report from Frost &...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Courting Resolution
By Kim Ribbink Product Litigation is Straining the Industry Product litigation has become an onerous fact of life for the pharmaceutical industry. Roughly 50 products are currently under active litigation in the United States, according to various industry sources. Legal experts say it’s not so m...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
CRM: Can it really be pulled off? Contributed by Ian Cross It’s official — all direct-to-consumer (DTC) ads now look the same. TV commercials have gone the way of concerned physicians depicted as animated characters who look like Pixar movie extras or the loving, older couples, who will never ret...
By Ian Cross • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Star Volunteer Sharon Callahan, president of Summit Grey, has been named as the 2006 HBA Star Volunteer by the Healthcare Businesswomen’s Association (HBA). Aside from leading the interactive agency, Ms. Callahan dedicates much of her time to HBA activities. She began her involvement in 1989 and ...
By PharmaVoice Team • Jan. 2, 2008
Previous
